Literature DB >> 35296813

Bispecific agonist boosts anti-tumour T cells via GITR.

Alexandra Flemming1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35296813     DOI： 10.1038/s41577-022-00708-1

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  1 in total

1.  An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy.

Authors:  Sarah Chan; Nicole Belmar; Sun Ho; Bryan Rogers; Marcia Stickler; Michelle Graham; Eileen Lee; Ninian Tran; Dong Zhang; Priyanka Gupta; Mien Sho; Tracy MacDonough; Andrew Woolley; Han Kim; Hong Zhang; Wei Liu; Pingping Zheng; Zoltan Dezso; Kyle Halliwill; Michele Ceccarelli; Susan Rhodes; Archana Thakur; Charles M Forsyth; Mengli Xiong; Siu Sze Tan; Ramesh Iyer; Marc Lake; Enrico Digiammarino; Li Zhou; Lance Bigelow; Kenton Longenecker; Russell A Judge; Cassie Liu; Max Trumble; Jonathan P Remis; Melvin Fox; Belinda Cairns; Yoshiko Akamatsu; Diane Hollenbaugh; Fiona Harding; Hamsell M Alvarez
Journal:  Nat Cancer       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.